Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Abiomed

This article was originally published in The Gray Sheet

Executive Summary

Abiomed: Receives $100,000 National Institute of Diabetes and Digestive and Kidney Diseases grant under the Small Business Innovation Research Program to develop a "laser-assisted tissue welding technique" that could act as an "alternative to conventional suture tying in bladder augmentation procedures," the firm announces June 9. Initial studies being conducted by the Danvers, Massachusetts-based firm will examine how to optimize laser use in urological tissue repair; later studies will focus on tissue healing characteristics. Abiomed also recently received a two-year grant worth "approximately $550,000" from the National Heart, Lung and Blood Institute for the completion of "development and pre-clinical testing" of a pulsatile cardiac assist pump "for temporary support of pediatric patients." The grant will allow Abiomed to complete product development prior to commencement of clinical trials. Initial clinical applications are planned for "cases involving post-operative support of neonates subsequent to the correction of congenital heart defects, and in children with cardiopulmonary compromise secondary to severe heart disease," the firm says...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT004213

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel